Impact of clinical and procedural factors upon C reactive protein dynamics following transcatheter aortic valve implantation

Table 1 Baseline patient characteristics

Variable	All patients (n = 208)
Age (yr)	81.4 ± 0.9
Female (%)	57 (27.4)
Diabetes mellitus (%)	34 (16.3)
Hypertension (%)	122 (58.7)
Dyslipidemia (%)	65 (31.3)
History of smoking (%)	34 (16.3)
NYHA III or IV (%)	94 (45.2)
Previous MI (%)	24 (11.5)
Previous CABG (%)	37 (17.8)
Previous PCI (%)	40 (19.2)
Cerebrovascular disease (%)	19 (9.1)
eGFR < 60 mL/min per 1.73 m2 (%)	42 (20.2)
Logistic EuroScore (%)	14.8 ± 1.4

NYHA: New York Heart Association; MI: myocardial infarction; CABG: Coronary artery bypass grafting; PCI: Percutaneous coronary intervention; eGFR: Estimated glomerular filtration rate.

Table 2 Thirty-day outcomes

	All patients (n = 208)
All-cause death	12 (5.8)
Coronary obstruction (%)	1 (0.05)
Stroke	9 (4.3)
PPM implantation	38 (18.3)
Minor vascular complication	8 (3.8)
Major vascular complication	8 (3.8)
Minor bleed	34 (16.3)
Major bleed	23 (11.1)
Life-threatening bleeding	8 (3.8)
Valve related dysfunction	0 (0)

PPM: Permanent pacemaker implantation.